Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Halmos

Showing results (71-80 of 78) with videos related to

Pageof 8
Sort By:
You have reached the last page of results.This site can display upto 78 results.
Diabetologia|July 8, 2005
Tesaglitazar, a novel dual peroxisome proliferator-activated receptor alpha/gamma agonist, dose-dependently improves the metabolic abnormalities associated with insulin resistance in a non-diabetic populationB Fagerberg, S Edwards, T Halmos, et al.
Bioorganic & Medicinal Chemistry Letters|January 5, 1999
Peptide-based inhibitors of the hepatitis C virus serine proteaseM Llinàs-Brunet, M Bailey, G Fazal, et al.
Bioorganic & Medicinal Chemistry Letters|October 31, 2000
Highly potent and selective peptide-based inhibitors of the hepatitis C virus serine protease: towards smaller inhibitorsM Llinàs-Brunet, M Bailey, G Fazal, et al.
Bioorganic & Medicinal Chemistry Letters|January 5, 1999
Studies on the C-terminal of hexapeptide inhibitors of the hepatitis C virus serine proteaseM Llinàs-Brunet, M Bailey, R Déziel, et al.
Orvosi Hetilap|January 25, 2000
[Detection of antibodies against pancreatic islet cells in clinical practice]P Pánczél, O Külkey, A Luczay, et al.
Orvosi Hetilap|January 5, 2002
[Latent autoimmune diabetes in adults(LADA): part of the clinical spectrum of type-1 diabetes mellitus of autoimmune origin]P Pánczél, N Hosszúfalusi, B Bornemisza, et al.
Bioorganic & Medicinal Chemistry|April 29, 1999
Discovery of non-peptidic P2-P3 butanediamide renin inhibitors with high oral efficacyB Simoneau, P Lavallée, P C Anderson, et al.
Journal of Medicinal Chemistry|December 24, 1997
Peptidomimetic inhibitors of the human cytomegalovirus proteaseW Ogilvie, M Bailey, M A Poupart, et al.
Pageof 8

Showing results (71-80 of 78) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 78 results.
Diabetologia|July 8, 2005
Tesaglitazar, a novel dual peroxisome proliferator-activated receptor alpha/gamma agonist, dose-dependently improves the metabolic abnormalities associated with insulin resistance in a non-diabetic populationB Fagerberg, S Edwards, T Halmos, et al.
Bioorganic & Medicinal Chemistry Letters|January 5, 1999
Peptide-based inhibitors of the hepatitis C virus serine proteaseM Llinàs-Brunet, M Bailey, G Fazal, et al.
Bioorganic & Medicinal Chemistry Letters|October 31, 2000
Highly potent and selective peptide-based inhibitors of the hepatitis C virus serine protease: towards smaller inhibitorsM Llinàs-Brunet, M Bailey, G Fazal, et al.
Bioorganic & Medicinal Chemistry Letters|January 5, 1999
Studies on the C-terminal of hexapeptide inhibitors of the hepatitis C virus serine proteaseM Llinàs-Brunet, M Bailey, R Déziel, et al.
Orvosi Hetilap|January 25, 2000
[Detection of antibodies against pancreatic islet cells in clinical practice]P Pánczél, O Külkey, A Luczay, et al.
Orvosi Hetilap|January 5, 2002
[Latent autoimmune diabetes in adults(LADA): part of the clinical spectrum of type-1 diabetes mellitus of autoimmune origin]P Pánczél, N Hosszúfalusi, B Bornemisza, et al.
Bioorganic & Medicinal Chemistry|April 29, 1999
Discovery of non-peptidic P2-P3 butanediamide renin inhibitors with high oral efficacyB Simoneau, P Lavallée, P C Anderson, et al.
Journal of Medicinal Chemistry|December 24, 1997
Peptidomimetic inhibitors of the human cytomegalovirus proteaseW Ogilvie, M Bailey, M A Poupart, et al.
Pageof 8